Can Price Transparency Contribute to More Affordable Patient Access to Medicines?
Pharmacoecon Open
.
2017 Sep;1(3):145-147.
doi: 10.1007/s41669-017-0028-1.
Authors
Sabine Vogler
1
,
Kenneth R Paterson
2
Affiliations
1
WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit Österreich GmbH (GÖG/Austrian Public Health Institute), Vienna, Austria. sabine.vogler@goeg.at.
2
University of Glasgow, Glasgow, Scotland, UK.
PMID:
29441499
PMCID:
PMC5691843
DOI:
10.1007/s41669-017-0028-1
No abstract available
Publication types
Editorial